Skip to main content
Log in

Off-label paediatric prescribing in Stockholm (Sweden): a response to a letter to the editor

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Ufer M, Rane A, Karlsson A, Kimland E, Bergman U (2003) Widespread off-label prescribing of topical but not systemic drugs for 350,000 paediatric outpatients in Stockholm. Eur J Clin Pharmacol 58:779–783

    PubMed  Google Scholar 

  2. Bucheler R, Meisner C, Kalchthaler B, Mohr H, Schroder H, Morike K, et al (2002) "Off-label" prescribing of drugs in the ambulatory care of children and adolescents. Dtsch Med Wochenschr 127:2551–2557

    Article  PubMed  Google Scholar 

  3. Bucheler R, Schwab M, Morike K, Kalchthaler B, Mohr H, Schroder H, et al (2002) Off label prescribing to children in primary care in Germany: retrospective cohort study. BMJ 324:1311–1312

    Article  PubMed  Google Scholar 

  4. Magrini N, Einarson T, Vaccheri A, McManus P, Montanaro N, Bergman U (1997) Use of lipid-lowering drugs from 1990 to 1994: an international comparison among Australia, Finland, Italy (Emilia Romagna Region), Norway and Sweden. Eur J Clin Pharmacol 53:185–189

    CAS  PubMed  Google Scholar 

  5. Larsen J, Vaccheri A, Andersen M, Montanaro N, Bergman U (2000) Lack of adherence to lipid-lowering drug treatment. A comparison of utilization patterns in defined populations in Funen, Denmark and Bologna, Italy. Br J Clin Pharmacol 49:463–471

    CAS  PubMed  Google Scholar 

  6. Bergman U, Andersen M, Vaccheri A, Bjerrum L, Wettermark B, Montanaro N (2000) Deviations from evidence-based prescribing of non-steroidal anti-inflammatory drugs in three European regions. Eur J Clin Pharmacol 56:269–272

    CAS  PubMed  Google Scholar 

  7. Vaccheri A, Bjerrum L, Resi D, Bergman U, Montanaro N (2002) Antibiotic prescribing in general practice: striking differences between Italy (Ravenna) and Denmark (Funen). J Antimicrob Chemother 50:989–997

    Article  CAS  PubMed  Google Scholar 

  8. Wettermark B, Pehrsson A, Jinnerot D, Bergman U (2003) Drug utilisation 90% profiles—a useful tool for quality assessment of prescribing in primary health care in Stockholm. Pharmacoepidemiol Drug Saf (in press)

  9. Sjöqvist F, Bergman U, Dahl ML, Gustafsson LL, Hensjö LO (2002) Drug and therapeutic committees: a Swedish experience. WHO Drug Inf 16:207–213

    Google Scholar 

  10. Ufer M, Kimland E, Bergman U (2003) Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden. Pharmacoepidemiol Drug Saf (in press)

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mike Ufer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ufer, M., Bergman, U. Off-label paediatric prescribing in Stockholm (Sweden): a response to a letter to the editor. Eur J Clin Pharmacol 59, 493–494 (2003). https://doi.org/10.1007/s00228-003-0644-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-003-0644-9

Keywords

Navigation